• Home
  • About Us
  • Clinical trials
  • News
  • Contacts
+7 (495)105 99 05 crd@ollamed.ru
  • Русский (Россия)
  • English (United Kingdom)
Департамент Клинических Исследований ООО Департамент Клинических Исследований ООО Департамент Клинических Исследований ООО
  • Home
  • About Us
  • Clinical trials
  • News
  • Contacts
Департамент Клинических Исследований ООО Департамент Клинических Исследований ООО Департамент Клинических Исследований ООО
  • Home
  • About Us
  • Clinical trials
  • News
  • Contacts

News

  • Home /
  • News /
  • Trials /
  • New study: Treating rheumatoid arthritis

New study: Treating rheumatoid arthritis

Super User
Trials
Read Time: 1 min
Created: 25 November 2022
Hits: 0

Permission was obtained from the Ministry of Health for the center to participate in a clinical trial of a new form of tocilizumab for patients with rheumatoid arthritis.

Search

Sections

  • Progress

  • Trials

  • Information

Last news

  • Completion of the study 25 Jun 2025
  • Evaluation of the possibility of conducting clinical trials of vaccines for the prevention of meningococcal and pneumococcal infections in the pediatric population. 06 May 2025
  • The visit of the selection center to participate in two studies of biological drugs for the treatment of IBD has been successfully completed. 08 Apr 2025

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen
Contact US
  • 8 (800) 444 06 68
  • ctd@ollamed.ru
  • 8А, 9-ya Parkovaya st., Moscow, Russia
  • Working time: 9:00-18:00 Mo-Fr

News

  • Completion of the study 25 Jun 2025
  • Evaluation of the possibility of conducting clinical trials of vaccines for the prevention of meningococcal and pneumococcal infections in the pediatric population. 06 May 2025
  • The visit of the selection center to participate in two studies of biological drugs for the treatment of IBD has been successfully completed. 08 Apr 2025
Copyright © 2026 Clinical trials department LLC "OLLA-MED"